Health
Azithromycin with QT-prolonging drugs may elevate CV event risk – Healio
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no diff…
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no difference between use of azithromycin and amoxicillin in risk for CV events, researchers reported.
Source: Adobe Stock.
“In this large cohort study including more than 4 million episodes of both azithromycin and amoxicillin use, we found no …
-
Business24 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News21 hours agoMan dies after stabbing in inner-city unit
-
Noosa News24 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General24 hours agoUK PM ready to ‘shelter’ businesses from tariff storm